Baby Safety / Compounds / Dexmedetomidine

Is Dexmedetomidine safe for babies and kids?

Context-dependent for kids

(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of Dexmedetomidine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

What is dexmedetomidine?

The IUPAC name is 5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole.

Also known as: Medetomidine, Medetomidina, Medetomidinum, Domitor.

IUPAC name
5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
CAS number
113775-47-6
Molecular formula
C13H16N2
Molecular weight
200.28 g/mol
SMILES
CC1=CC(=CC(C)=C1)[C@@H](C)NC
PubChem CID
68602

Risk for babies

Context-dependent

Pregnancy alters the metabolism and distribution of Dexmedetomidine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Dexmedetomidine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

2 regulatory and scientific bodies have classified Dexmedetomidine. The classifications differ — that's the data.

AgencyYearClassificationNotes
FDA1999Approved human drug (NDA 021038, Precedex) and veterinary (Dexdomitor, Sileo)
DEA2020Not a controlled substance

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter dexmedetomidine

  • Pharmaceutical

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Dexmedetomidine:

  • Acepromazine (no analgesic effect but less cardiovascular impact)
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.
    Relative cost: 1.2-2×
  • Midazolam (benzodiazepine sedation)
    Trade-offs: Alternative approach; specific tradeoffs depend on application context, scale, and regulatory requirements. Full hazard assessment of alternative recommended before adoption to avoid regrettable substitution.
    Relative cost: 1.2-2×

Frequently asked questions

No FAQ entries generated.

See Dexmedetomidine in the baby app

Look up products containing dexmedetomidine, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. —

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →